Cancer Genetics Inc.

Contact CGI:Contact Us | Email

Investors
Facebook Twitter LinkedIn YouTube
  • Home
  • About CGI
    • Company Overview
    • Board of Directors
    • Management Team
    • Collaborations
    • Careers
    • Media
      • Articles
      • Shared Insights
      • Events
      • Press Releases
      • Videos
      • Webinars
    • Contact CGI
  • Clinical Testing
    • Test Menu
      • By Methodology
      • By Disease
    • Specialty Tests
      • FHACT®
      • Focus::NGS®
      • MatBA®
      • Tissue of Origin®
      • UroGenRA®
    • Complete™ Program
    • Technical Only Testing
    • Summation Report
    • Licensure
  • Clinical Trials
    • Overview
    • Biomarker Solutions
    • Genomics Services
      • Focus::NGS®
      • Genotyping
      • Gene Expression
      • Nucleic Acid Extraction & Purification
    • Pharmacogenomics Services
    • Integrated Biorepository
    • Consulting Services
    • Clinical Trials FAQs
    • Shared Insights
  • Pharmacogenomics
    • Pharmacogenomic Services
    • Pharmacogenomic Testing
  • Research
    • Patents
    • Array-CGH
    • FHACT®
    • Publications
    • Oncospire Genomics™
  • Patient Resources
    • Personalized Medicine
    • Medical Assistance Program
    • ICD-10 FAQs and Reference Guide
    • Advocacy Groups
    • Patient FAQs
    • Glossary

Navigate

About CGI Media Contact CGI Investors Clinical Testing Test Menu Specialty Tests FHACT® Focus::NGS™ MatBA® UroGenRA® Complete™ Program Technical Only Testing Summation™ Report Licensure Clinical Trials Pharmacogenomics Research Patient Resources
Media
  • Videos
  • Webinars
  • Articles
  • Events
  • Press Releases
  • Shared Insights

ACOG Annual Clinic & Scientific Meeting

Scheduled For: Saturday, May 2nd, 2015 View all Events

Date: May 2 -6, 2015
Location: San Francisco, CA
Booth #: 1728
Website: ACOG Annual Clinic & Scientific Meeting

Share this:

  • Tweet
  • More
  • Print
  • Pocket
> Additional Videos
  • Cancer Genetics offers the FDA-approved DAKO PD-L1 IHC 22C3 pharmDx companion diagnostic test for KEYTRUDA®
  • Cancer Genetics is a center of excellence for oncology-focused clinical trials.
  • Cancer Genetics offers an integrated solution for clinical trials.
  • Cancer Genetics offers an integrated solution for Clinical Trials.
  • Predicting response, improving patient outcome
  • Cancer Genetics, a global partner for biopharma companies
> Additional Articles
  • A novel partnership takes aim at developing NGS companion diagnostics in oncology
  • Room for “Precision Oncology – A centrepiece of cancer care in the 21st century”
  • Looking for Cancer Clues in the Bloodstream
  • Cancer Genetics Offers New Immuno-Oncology Testing Portfolio
  • Understanding the Basics of Cancer Genetics
  • The Genetics of Cancer

> Join Our Mailing List

  • About CGI
    • Company Overview
    • Board of Directors
    • Scientific Advisory Board
    • Management Team
    • Collaborations
    • Media
    • Careers
    • Contact Us
  • Clinical Testing
    • Test Menu
    • Specialty Tests
    • Complete Program
    • Technology Only Testing
    • Summation Report
    • Licensure
  • Specialty Tests
    • FHACT®
    • Focus::NGS®
    • MatBA®
    • Tissue of Origin®
    • UroGenRA®
  • Clinical Trials
    • Overview
    • Biomarker Solutions
    • Genomics Services
    • Pharmacogenomics
    • Integrated Biorepository
    • Consulting Services
    • Clinical Trials FAQs
    • Shared Insights
  • Pharmacogenomics
    • Pharmacogenomic Services
    • Pharmacogenomic Testing
  • Research
    • Patents
    • Array-CGH
    • FHACT®
    • Publications
    • Oncospire Genomics™
  • Patient Resources
    • Personalized Medicine
    • Medical Assistance Program
    • Advocacy Groups
    • Patient FAQs
    • Glossary

© Copyright 2019 Cancer Genetics Inc. All Rights Reserved.

  • Employees
  • Legal and Privacy